• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Rotavirus Vaccination of Premature Newborns in the NICU: Evaluation of Vaccination Rates and Safety Based on a Single-Centre Study.新生儿重症监护病房中早产儿的轮状病毒疫苗接种:基于单中心研究的疫苗接种率及安全性评估
Vaccines (Basel). 2023 Jul 26;11(8):1282. doi: 10.3390/vaccines11081282.
2
Safety of Rotavirus Vaccination in Preterm Infants Admitted in Neonatal Intensive Care Units in Sicily, Italy: A Multicenter Observational Study.意大利西西里岛新生儿重症监护病房收治的早产儿轮状病毒疫苗接种安全性:一项多中心观察性研究
Vaccines (Basel). 2023 Mar 23;11(4):718. doi: 10.3390/vaccines11040718.
3
Parents' experiences of transition when their infants are discharged from the Neonatal Intensive Care Unit: a systematic review protocol.婴儿从新生儿重症监护病房出院时父母的过渡经历:一项系统综述方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):123-32. doi: 10.11124/jbisrir-2015-2287.
4
Rotarix® and RotaTeq® administration to preterm infants in the neonatal intensive care unit: Review of available evidence.罗特律®和罗特佳®在新生儿重症监护病房中用于早产儿:现有证据的回顾。
Vaccine. 2018 Aug 28;36(36):5430-5434. doi: 10.1016/j.vaccine.2017.10.013. Epub 2017 Oct 14.
5
Incidence, Clinical Characteristics, and Genotype Distribution of Rotavirus in a Neonatal Intensive Care Unit 5 Years After Introducing Rotavirus Vaccine.引入轮状病毒疫苗5年后新生儿重症监护病房轮状病毒的发病率、临床特征及基因型分布
Front Pediatr. 2022 Feb 17;10:850839. doi: 10.3389/fped.2022.850839. eCollection 2022.
6
Rotavirus vaccination in the neonatal intensive care units: where are we? A rapid review of recent evidence.新生儿重症监护病房中的轮状病毒疫苗接种:我们在哪里?近期证据的快速综述。
Curr Opin Pediatr. 2020 Feb;32(1):167-191. doi: 10.1097/MOP.0000000000000869.
7
Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.超过 15 年人轮状病毒疫苗(罗特律克)上市后安全性监测自发数据的综述:肠套叠。
Drug Saf. 2022 Feb;45(2):155-168. doi: 10.1007/s40264-021-01141-4. Epub 2022 Jan 11.
8
[Recommendations for vaccination against ROTAvirus in PREMature newborns (ROTAPREM)].[关于早产儿轮状病毒疫苗接种的建议(ROTAPREM)]
An Pediatr (Engl Ed). 2019 Sep;91(3):205.e1-205.e7. doi: 10.1016/j.anpedi.2019.06.001. Epub 2019 Jul 6.
9
Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.新生儿重症监护病房中五价轮状病毒疫苗的评估
Vaccine. 2015 Sep 22;33(39):5095-102. doi: 10.1016/j.vaccine.2015.08.015. Epub 2015 Aug 18.
10
Rotavirus vaccination of very low birth weight infants at discharge from the NICU.极低出生体重儿在新生儿重症监护病房出院时接种轮状病毒疫苗。
Pediatrics. 2013 Sep;132(3):e662-5. doi: 10.1542/peds.2013-0291. Epub 2013 Aug 12.

引用本文的文献

1
Rotavirus Vaccine Administration in Preterm and Medically Fragile Infants Admitted to Neonatal Intensive Care Units: Second Phase Enrollments and Final Results of a Multicenter Observational Study Conducted in Sicily, Italy.入住新生儿重症监护病房的早产儿和医学上脆弱婴儿的轮状病毒疫苗接种:在意大利西西里岛进行的多中心观察性研究的第二阶段入组及最终结果
Vaccines (Basel). 2025 Jan 21;13(2):100. doi: 10.3390/vaccines13020100.

本文引用的文献

1
Safety of Rotavirus Vaccination in Preterm Infants Admitted in Neonatal Intensive Care Units in Sicily, Italy: A Multicenter Observational Study.意大利西西里岛新生儿重症监护病房收治的早产儿轮状病毒疫苗接种安全性:一项多中心观察性研究
Vaccines (Basel). 2023 Mar 23;11(4):718. doi: 10.3390/vaccines11040718.
2
Current Update on Rotavirus in-Silico Multiepitope Vaccine Design.轮状病毒计算机多表位疫苗设计的最新进展
ACS Omega. 2022 Dec 30;8(1):190-207. doi: 10.1021/acsomega.2c07213. eCollection 2023 Jan 10.
3
Incidence, Clinical Characteristics, and Genotype Distribution of Rotavirus in a Neonatal Intensive Care Unit 5 Years After Introducing Rotavirus Vaccine.引入轮状病毒疫苗5年后新生儿重症监护病房轮状病毒的发病率、临床特征及基因型分布
Front Pediatr. 2022 Feb 17;10:850839. doi: 10.3389/fped.2022.850839. eCollection 2022.
4
Rotavirus Vaccine Safety and Effectiveness in Infants With High-Risk Medical Conditions.轮状病毒疫苗在具有高危医疗条件的婴儿中的安全性和有效性。
Pediatrics. 2021 Dec 1;148(6). doi: 10.1542/peds.2021-051901.
5
The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review.已获许可的轮状病毒疫苗的性能及新一代轮状病毒疫苗的研发:综述
Hum Vaccin Immunother. 2021 Mar 4;17(3):880-896. doi: 10.1080/21645515.2020.1801071. Epub 2020 Sep 23.
6
Role of the Microbiota in the Modulation of Vaccine Immune Responses.微生物群在疫苗免疫反应调节中的作用。
Front Microbiol. 2019 Jul 3;10:1305. doi: 10.3389/fmicb.2019.01305. eCollection 2019.
7
Rotavirus vaccine efficacy: current status and areas for improvement.轮状病毒疫苗效力:现状和改进领域。
Hum Vaccin Immunother. 2019;15(6):1237-1250. doi: 10.1080/21645515.2018.1520583. Epub 2018 Sep 19.
8
Biophysical properties of single rotavirus particles account for the functions of protein shells in a multilayered virus.单轮状病毒颗粒的生物物理特性解释了蛋白质外壳在多层病毒中的功能。
Elife. 2018 Sep 11;7:e37295. doi: 10.7554/eLife.37295.
9
Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.高收入、低流行地区两种婴幼儿轮状病毒疫苗接种策略的成本效益和风险效益分析更新。
BMC Med. 2018 Sep 10;16(1):168. doi: 10.1186/s12916-018-1134-3.
10
Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016.2008年至2016年向疫苗不良事件报告系统(VAERS)报告的服用第一剂轮状病毒疫苗(罗特威和Rotarix)后出现下呼吸道感染的情况。
Hum Vaccin Immunother. 2018;14(11):2755-2759. doi: 10.1080/21645515.2018.1491509. Epub 2018 Jul 26.

新生儿重症监护病房中早产儿的轮状病毒疫苗接种:基于单中心研究的疫苗接种率及安全性评估

Rotavirus Vaccination of Premature Newborns in the NICU: Evaluation of Vaccination Rates and Safety Based on a Single-Centre Study.

作者信息

Marcinek Klaudia, Zapolnik Paweł, Radziszewska Renata, Ochoda-Mazur Agnieszka, Czajka Hanna, Pawlik Dorota

机构信息

Neonatology Clinical Department, University Hospital in Kraków, 31-501 Kraków, Poland.

College of Medical Sciences, University of Rzeszów, 35-315 Rzeszów, Poland.

出版信息

Vaccines (Basel). 2023 Jul 26;11(8):1282. doi: 10.3390/vaccines11081282.

DOI:10.3390/vaccines11081282
PMID:37631849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10458254/
Abstract

Preterm newborns are babies born before the end of the 36th week of gestational life. They are at increased risk of infection and death from infectious diseases. This is due, among other things, to the immaturity of the immune system and the long hospitalisation period. One common infectious disease in the paediatric population is rotavirus (RV) infection. We now have specific vaccines against this pathogen. The aim of this study was to evaluate the safety of rotavirus vaccination in the neonatal intensive care unit (NICU) setting and to determine the tolerance of this vaccine in low- and extremely low-weight children. The study carried out at a single centre, the University Hospital in Kraków, also allowed the assessment of vaccination trends during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. During the observation period, 126 premature newborns received the RV vaccine. We observed no adverse effects, and our analysis shows safety and good tolerance of the vaccine among preterm babies. In addition, we observed an increase in vaccination rates between 2019 and 2021, partly explained by parents' anxiety about infectious diseases in the era of pandemics and partly explained by a change in vaccination policy in Poland and the introduction of refunding for RV vaccination.

摘要

早产儿是指在妊娠36周结束前出生的婴儿。他们感染传染病以及因传染病死亡的风险更高。这尤其归因于免疫系统不成熟和住院时间长。儿科人群中一种常见的传染病是轮状病毒(RV)感染。我们现在有针对这种病原体的特定疫苗。本研究的目的是评估在新生儿重症监护病房(NICU)环境中接种轮状病毒疫苗的安全性,并确定该疫苗在低体重和极低体重儿童中的耐受性。在克拉科夫大学医院这一单一中心开展的这项研究,还能评估严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行期间的疫苗接种趋势。在观察期内,126名早产新生儿接种了RV疫苗。我们未观察到不良反应,我们的分析表明该疫苗在早产婴儿中具有安全性和良好的耐受性。此外,我们观察到2019年至2021年期间疫苗接种率有所上升,部分原因是父母在大流行时代对传染病的焦虑,部分原因是波兰疫苗接种政策的变化以及引入了RV疫苗接种退款。